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Progress on Toxin Structural
Character
Florida red tide inhalation toxicity has been
documented in the Western literature since
1844. Earlier accounts from Spanish explor-
ers of an “irritating essence” predate 1600.
Past explanations for Florida red tide respira-
tory distress have included World War I
nerve gas release (Galtsoff 1948), “fast”- and
“slow”-acting toxins (McFarren et al. 1965), a
phosphorylated organic molecule (Martin and
Chatterjee 1969), and green particles as frag-
ments of a marine alga (Woodcock 1948).
Descriptions of Florida red tide complexity
have mirrored increases in capability of analyt-
ical detection. Before 1970, the description of
red tides was based on environmental observa-
tions of irritating aerosols, fish-killing sub-
stances, and hemolytic factors [reviewed in
Baden (1983, 1989)]. Because such small
amounts of bioactive material were necessary
to elicit the toxicologic responses, much of the
initial pharmacology/toxicology was under-
stood long before toxin structures were
known. Investigators in the early 1970s, using
the new field of high-performance liquid
chromatography, purified two toxins with
very similar spectroscopic characteristics, their
differences being the presence of either an
exomethylene-conjugated aldehyde or the cor-
responding allylic alcohol. These two materi-
als of “interchangeable nature” (T46 and T47,
or T17 and T34) later became known as the
polyether brevetoxins PbTx-3 and PbTx-2,
respectively (Baden 1977; Catterall and Risk
1981; Poli et al. 1986). The structure of
PbTx-2 (brevetoxin B) was determined by
Nakanishi’s group in 1981 to be a trans-fused
polyether ladder toxin with syn relative stereo-
chemistry across each side of the molecule
(Lin et al. 1981). Additional toxins were struc-
turally characterized by comparison with the
PbTx-2 spectroscopic data; PbTx-3 was pro-
posed as the reduced form of PbTx-2 by
Baden and Mende (1981) and Chou and col-
leagues (Chou et al. 1985; Shimizu et al.
1990). Subsequent reduction of PbTx-2 with
tritium-labeled sodium borohydride allowed
Baden and colleagues to produce isotopically
labeled brevetoxin with sufficient specific
activity for radioimmunoassays (Baden et al.
1984) and later to characterize the brevetoxin
binding site in rat brain synaptosome sodium
channels (Poli et al. 1986).
Shimizu et al. (1986) described
brevetoxin A, possessing a slightly different
polyether backbone, from cultures of Karenia
brevis. This molecule, denoted PbTx-1, is very
similar to the PbTx-2 structure in that both
possess lactone functionality in the A-ring and
a series of relatively rigid rings that form a lad-
der structure, and both terminate in an identi-
cal, very reactive α,β-unsaturated aldehyde
side chain. It is noteworthy that PbTx-1 is the
only natural toxin known to possess rings with
ﬁve, six, seven, eight, and nine members, all in
the same molecule. Seven additional structures
followed in quick succession (Figure 1), the
structures being determined by comparison of




By molecular modeling, Rein et al. (1994a,
1994b) and Gawley et al. (1995) determined
that the structures of both PbTx-1 and PbTx-2
are relatively linear with a bend approximately
mid-molecule, possess a lactone functionality in
the A-ring, have a strictly rigid region in the
terminal four rings, possess a side chain allow-
ing modest modiﬁcation at the molecules’ ter-
mini, and have a spacer region that separates
the rigid region from the A-ring lactone. All
natural brevetoxins and synthetic derivatives
with full activity possess all these features.
Numerous publications describe many of the
salient features of the brevetoxin molecules and
cite the modulating effects of altering the lac-
tone functionality, of changing the nature of
the side chain, of inducing additional ﬂexibility
in the middle of the molecule, or combinations
thereof [e.g., Jeglitsch et al. (1998); Purkerson
et al. (1999)]. All derivatives of natural toxin
examined to date reduce toxicity; that is, no
derivative has been produced synthetically that
is more toxic than PbTx-1 or PbTx-2, the tox-
ins reputed to be the parent molecules. In fact,
it can be argued that all other natural toxins are
produced biosynthetically by K. brevis using the
two parent backbones as precursors.
Nicoloau et al. (1995) had produced
totally synthetic brevetoxin PbTx-2, which
had receptor binding properties and spec-
troscopy identical to the natural material,
confirming that the structure proposed by
Lin et al. (1981) was indeed correct.
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Symptoms consistent with inhalation toxicity have long been associated with Florida red tides,
and various causal agents have been proposed. Research since 1981 has centered on a group of
naturally occurring trans-fused cyclic polyether compounds called brevetoxins that are produced
by a marine dinoﬂagellate known as Karenia brevis. Numerous individual brevetoxins have been
identiﬁed from cultures as well as from natural bloom events. A spectrum of brevetoxin derivatives
produced by chemical modiﬁcation of the natural toxins has been prepared to examine the effects
of functional group modiﬁcation on physiologic activity. Certain structural features of natural and
synthetic derivatives of brevetoxin appear to ascribe specific physiologic consequences to each
toxin. Differential physiologic effects have been documented with many of the natural toxins and
derivatives, reinforcing the hypothesis that metabolism or modiﬁcation of toxin structures modu-
lates both the specific toxicity (lethality on a per milligram basis) and potentially the molecular
mechanism(s) of action. A series of naturally occurring fused-ring polyether compounds with
fewer rings than brevetoxin, known as brevenals, exhibit antagonistic properties and counteract
the effects of the brevetoxins in neuronal and pulmonary model systems. Taken together, the
inhalation toxicity of Florida red tides would appear to depend on the amount of each toxin pre-
sent, as well as on the spectrum of molecular activities elicited by each toxin. Toxicity in a bloom
is diminished by the amount brevenal present. Key words: brevenal, brevetoxin, Florida red tide,
immunotoxicant, Karenia brevis, neurotoxin, PbTx, polyether, pulmonary toxicant. Environ
Health Perspect 113:621–625 (2005). doi:10.1289/ehp.7499 available via http://dx.doi.org/
[Online 10 February 2005]Subsequent synthesis of the brevetoxin A
molecule (PbTx-1) was likewise accomplished
(Nicoloau et al. 1998). The production of
truncated brevetoxin by Nicoloau and col-
leagues, a compound possessing all of the
“required” features of intact brevetoxin except
for the B–E ring spacer region, was essentially
inactive in patch-clamp experiments (Gawley
et al. 1995), although it had some afﬁnity for
receptor site 5 on the sodium channel.
As a result of the multiplicity of effects
demonstrated by this combination of metabol-
ically relevant structural modiﬁcations, recep-
tor binding pharmacology, and single-channel
kinetic studies, it was postulated that Florida
red tide potency in situ would be a complex
phenomenon and the toxicologic consequences
of red tides would be based on the amounts
and activities of the brevetoxins present (Baden
and Tomas 1988; Steidinger and Baden 1984).
The purpose of this mini-monograph
introduction is to describe the complex nature
of exposure to Florida red tide toxins, as refer-
ence for articles presented later in this mono-
graph (Figure 2). Although most of the
studies have been conducted with PbTx-3 (a
natural toxin possessing all of the requisite
structural characteristics for full activity), the
investigators acknowledge that many studies
will require repetition for toxins missing one
or more activity loci, or for complex mixtures
that may include metabolites and antagonists
in addition to toxin. Presumably, any bioac-
tive agents produced by the toxigenic organ-
ism or any metabolites free in the water have
the potential to become aerosolized. Further,
we believe that the overall signs and symp-
toms observed in humans will depend on the
particular combination of activities elicited
by the toxins and derivatives/metabolites
(Jeglitsch et al. 1998).
We restrict ourselves to a discussion of
those toxins, antagonists, and metabolites that
have been described from seawater or culture
medium, although we realize that aerosols
may contain cell particles and organelles
(Woodcock 1948) as well as bacteria, fungi,
and other organic materials in the mixed
microlayer of the coastal ocean (Zobell 1942).
The metabolites produced by shellfish, fish,
and other marine creatures, although extremely
important for seafood poisonings, are not con-
sidered to be relevant to inhalation toxicology,
and they have not been detected by us in air
ﬁlters (Cheng et al. 2005).
Figure 3 illustrates the model “brevetoxin”
that encompasses all the salient features of tox-
ins that are “fully active” at their binding site,
voltage-sensitive sodium channels (VSSCs;
membrane potential-gated ion channels)
(Baden et al. 1996). Modeling work initiated
by Gawley et al. (1995) described a brevetoxin
PbTx-2 molecule believed to be composed of
three distinct segments: a relatively rigid four-
ring H–K ring system, an A-ring lactone, and
a B–G ring region with limited flexibility.
Homologous ring systems exist in the breve-
toxin A backbone. All active toxins have these
essential characteristics whether they are mem-
bers of the brevetoxin B backbone or the
brevetoxin A backbone (Figure 1).
Active toxins bind to site 5 on the α-sub-
unit of the VSSC (Poli et al. 1986) and are
thought to orient “head-down” into the chan-
nel (Gawley et al. 1995), intercalating between
the α-helices of domains III and IV of the
VSSC (Trainer et al. 1994) (Figure 4).
The α-subunit is a single polypeptide gly-
coprotein, which possesses a 4-fold homology.
Each homologous domain contains six trans-
membrane α-helices (S1–S6), which alter-
nately extend through the membrane, with
short-to-long trans-helical peptide regions.
Three of the helices in each domain are neu-
tral in charge; two of the helices are hydro-
phobic, and one helix in each domain is
highly positively charged. The highly charged
S4 helix in each domain is thought to respond
allosterically to changes in membrane poten-
tial, a “voltage sensor.” Allosteric realignment
of all four S4 helices results in a change in
channel configuration from “closed” (C), to
“open” or conducting (O). Channels inacti-
vate or become nonconducting (I) by internal
insertion of the isoleucine–phenylalanine–
methionine tripeptide region of the intra-
cellular polypeptide connecting domains III
and IV into the ion-conducting central pore.
Normally, VSSCs open in response to
membrane depolarization and subsequently
inactivate in the late phase after activation.
Channels return to the allosterically closed
conﬁguration during membrane repolarization
(Taylor 1994). All natural brevetoxins have
four distinct activities that alter the normal
C→O→I triad of VSSCs: a) the activation
potential is shifted to more negative potentials,
favoring a C→O allosteric change at normal
Mini-Monograph | Baden et al.
622 VOLUME 113 | NUMBER 5 | May 2005 • Environmental Health Perspectives
Figure 1. Brevetoxins are based on two different structural backbones, based on what are perceived to be
the two parent molecules, PbTx-2 (brevetoxin B) and PbTx-1 (brevetoxin A). All other known derivatives
are based on alteration of the R-side chain, epoxidation across the double bond in the H-ring of PbTx-2, or
derivatization at the C-37 hydroxyl in PbTx-2. PbTx-8, the chloromethyl ketone derivative of PbTx-2, is an
artifact of chloroform extraction and subsequent phosgene conversion of PbTx-2. Common features
include trans-fused polyether ring systems consisting of ﬁve- to nine-membered rings.
*Denotes likely chemical artifact from extraction.
Brevetoxin B backbone Brevetoxin A backbone




Brevetoxin B backbone, R =
PbTx-2, CH2C(=CH2)CHO
PbTx-3, CH2C(=CH2)CH2OH
PbTx-5, [PbTx-2], C-37 OAc
PbTx-6, [PbTx-2], H-ring epoxide
PbTx-8*, CH2COCH2Cl
PbTx-9, CH2CH(CH3)CH2OH
Figure 2. Complexity of lethal components isolated
from Florida red tide: the explanation for the
potency of red tide events is summarized from 1980
to the present. 1981: only one specific toxin had
been identified. Lethality of red tides was thought
to be directly related to the concentration of toxi-
genic organism and the toxin it produced. Mid-
1980s: characterization of multiple toxins with
widely varying potencies. Lethality was thought to
arise from additive effects of each toxin present.
Early 1990s: the second brevetoxin structural back-
bone (PbTx-1) and multiple derivatives discovered
and thought to be more potent than the corre-
sponding toxins based on the PbTx-2 backbone.
Early 21st century: brevenal described as the first
naturally occurring antagonist to counteract the
effects of brevetoxins in radioligand binding
assays, in ﬁsh and mouse bioassays, and in respi-
ratory protocols. (The pulmonary receptor for
brevetoxins and brevenal may be distinct from the
well-characterized brevetoxin binding site on neu-
ronal VSSC described in the text.)
1980—One chemically characterized brevetoxin
 with a specific toxicity
1985—Multiple characterized brevetoxins,
each with its own specific toxicity
1990—Multiple brevetoxins, based on
two different structural backbones
1995—Multiple brevetoxins and
active brevetoxin metabolites
2000—Multiple brevetoxins and metabolites,
modulated by a polyether antagonist brevenal
2005—Multiple brevetoxins and metabolites,
modulated by multiple brevenal structuresresting potential; b) a longer mean open
time O, which can be inﬂuenced by a number
factors, but which results in the channel being
in the open conﬁguration longer; c) an induc-
tion of sodium ion subconductance states in
addition to the normal 21 pS rate; and d)a n
inhibition of inactivation O→I. Derivatives of
natural toxin produced in the laboratory, as
well as metabolites, knock out one or more of
the observed activities in single ion channel
patch-clamp experiments. The resulting over-
all consequences of exposure to multiple nat-
ural toxins and metabolites are complex and
difficult to quantify mechanistically. How
metabolites or modifications to toxin loci
modulate activity is summarized in Table 1. 
Experimental evidence suggests the H–K
rings system is essential for binding, and all
toxins and derivatives that are bioactive possess
this ring system. The B–G ring system is a
spacer region that separates binding from an
activity locus, the A-ring. The intact A-ring
lactone modulates both inactivation activity
and mean open time in single-channel patch-
clamp experiments (Jeglitsch et al. 1998;
Purkerson-Parker et al. 2000). Details of the
molecular pharmacology of brevetoxin and
derivatives are reviewed in Baden and Adams
(2000) and summarized in Table 1. We
believe that, depending on the type of toxin
decomposition that occurs during the declin-
ing phases of a Florida red tide, different
inhalation effects may be evident based on
pharmacophore absence or presence. Detailed
work with bioactive polyethers possessing only
some of the activity characteristics of fully
active toxin have not been carried out, but dif-
ferential inhalation symptoms have been expe-
rienced during active red tides [Pierce RH,
personal communication (15 April 2004);
Backer et al. 2005; Fleming et al. 2005].
Figure 5 illustrates the recently elucidated
structures of PbTx-11 through PbTx-14
(Bourdelais and Baden 2004; Bourdelais et al.,
unpublished results). Like PbTx-8, which is an
artifact of the aqueous chloroform extraction
of PbTx-2, PbTx-13, and PbTx-14 are likely
artifacts of acid-catalyzed methanol addition
during puriﬁcation protocols. All three breve-
toxin artifacts illustrate the highly reactive
nature of the conjugated side chain in the
PbTx-2 molecule. By analogy, the side chain
of PbTx-1 ought to be equally reactive. This
side chain also interacts with nucleophiles
to form adducts: the presumed cathepsin
inhibitory activity is thought to reside in the
active cysteine of cathepsin B, H, and L and of
papain (Sudaranam et al. 1992). Such activity
might impart an immune suppression in
exposed individuals (Benson et al. 2005).
PbTx-11, PbTx-12, and PbTx-tbm
(brevetoxin PbTx-2 lacking the side chain tail)
are new toxins found in cultures and in the
field (Abraham et al. 2005; Bourdelais and
Baden 2004; Bourdelais et al., unpublished
results). Their toxicology is almost completely
unknown except that they competitively bind
at site 5 on the sodium channel (Bourdelais
and Baden 2004; Bourdelais et al. 2004).
Figure 6 shows the chemical structure of
brevenal, the antagonistic material isolated
from both laboratory cultures and bloom
waters (Bourdelais et al. 2004, in press).
Brevenal derivatives have also been detected in
our cultures. Brevenal resembles hemibreve-
toxin, isolated by Shimizu et al. (1990).
Cytotoxicity was reported for hemibrevetoxin,
but no antagonistic activity was recorded. 
From the data collected, it is important to
note again that not only are there two struc-
tural backbones for the brevetoxin molecules,
but there are at least 13 different derivatives
thereof, and each of these derivatives possesses
a speciﬁc toxicity that is correlated to its bind-
ing affinity on VSSCs. However, from past
work it is clear that derivatives produced at
speciﬁc loci on the brevetoxin backbone impart
a differential set of “activities” that encompass
effects on activation potential, mean open
time, inactivation, and persistent depolariza-
tion due to subconductance state prevalence.
Relationship of Toxin Multiplicity
to Environmental Episodes 
of Pulmonary Exposure
Many of the examined derivatives can be
produced by intermediary metabolism and
environmental decomposition, suggesting that
environmental episodes may exhibit great vari-
ation in both degree and effect (Baden and
Tomas 1988; Ingle 1954). The added pres-
ence of the brevenals would tend to moderate
the overall consequences. Its waxing and wan-
ing presence during a red tide may provide a
partial explanation for anecdotal accounts of
high toxigenic organism cell counts in the
absence of pronounced ﬁsh kills or respiratory
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Figure 4. (A) A model depicting the sodium-channel α-subunit three-dimensional structure and hypothe-
sized orientation of brevetoxin “head”-down” between domains III and IV. The view from above (at far left)
illustrates a possible orientation relative to the α-helices, which are shown as colored circles. (B) Diagram
illustrating the putative triad of VSSC conﬁgurations and alterations produced by brevetoxins. All natural
brevetoxins a) shift the activation potential, favoring the open (O) conﬁguration at normal resting potential
(thick arrow); b) produce a longer mean open time (O); c) induce subconductance states (O1, O2, etc.); and
d) inhibit inactivation (O→I). Figure adapted from Gawley et al. (1995), Taylor (1994), Rein et al. (1994a,






Figure 3. All active brevetoxins have several requi-
site features that result in complete expression of
brevetoxin activities: a relatively rigid H–K ring
region (G–J region in PbTx-1) thought to be involved
in binding at site 5 of the VSSCs on the α-subunit
(“rigid region”); an A-ring electrophile of some type,
in most cases a ﬁve- or six-membered ring lactone
(“head”); a several-ring “spacer” region that sepa-
rates the binding region from the activity region;
and a side chain (“tail”; Gawley et al. 1995).
Table 1. Effect of toxin modiﬁcation on the ﬁve expressed activities of natural brevetoxins.a
Toxin Shift Subconductance Longer  mean Inhibit  Toxin
modiﬁcation activation statesb open time inactivation antagonist
Natural toxins  Yes Yes (1) Yes Yes No
Modiﬁed A-ring Yes No No Yes No
Open A-ring Yes Yes (4) Yes Yes No
Short spacer region Yes No No No No
Bulky side chain Yes No No No Yes
Saturated H-ring Noc No No No No
Brevenal ND ND ND ND Yes
ND, not determined. 
aCompiled from Baden et al. (1996), Bourdelais et al. (2005, in press), and Gawley et al. (1992). bIn addition to the normal
21 pS conductance. cHas no afﬁnity for site 5.irritation, or of relatively low cell counts and
reports of “respiratory irritation” (Fleming
et al. 2005).
What is there to say, then, about the over-
all pulmonary effects of these polyether natural
products? First, in 1947 Woodcock collected
droplets of vapor from active red tides and
from normal seawater. The droplets from the
red tide areas differed signiﬁcantly from those
from non-red tide areas (Woodcock 1948).
Red tide aerosol droplets contained small,
greenish granules similar in color and shape to
those observed in the red tide organism
(K. brevis). The granules, which were approxi-
mately 1–2 µm in diameter, are an ideal size to
become delivery vehicles for pulmonary expo-
sure. Evident from Woodcock’s work is not
only that respiratory irritants become airborne
from red tides but also that actual particles of
the organism become airborne as well. Were
these particles to be the delivery mechanism for
at least part of the inhaled red tide brevetoxins,
then it could be concluded that any toxin or
metabolite present in the organism has the
potential to be inhaled—perhaps as part of an
intracellular storage granule or organelle. The
search for the storage depot of brevetoxins in
the K. brevis organism has been fruitless.
Density centrifugation of whole Karenia cells
indicates that the toxins are intracellular
(Baden 1977). Density centrifugation of cell
lysates fails to reveal any concentration of
brevetoxins within any subcellular particle
(Baden DG and Bishop B, unpublished obser-
vations). Nor has immunologic staining of the
organism for toxin produced satisfactory results
(Naar J, unpublished observations).
As described by Abraham et al. (2005), the
brevetoxins have effects at 1,000-fold lower
concentrations in pulmonary systems than
they have in any neuronal system studied to
date. Moreover, the relative concentrations of
toxin and antagonist in the pulmonary system
are reversed from those exhibited by neuronal
systems. That is to say, brevenal is a more
potent antagonist in pulmonary systems than
it is in neuronal or fish bioassays. This is an
interesting set of data because it tends to sup-
port the contention that there is something
very different about the pulmonary receptor
when compared with site 5 of VSSC in the
central nervous system. Either way, further
exploration of the binding phenomenon in
pulmonary tissues is warranted.
The complex mixtures presented by
Florida red tides (Cheng et al. 2005), all of
which are known to bind to a single class of
orphan receptors associated with VSSC site 5
(Gawley et al. 1992; Poli et al. 1986), provide
insight into the neuronal effects of brevetox-
ins. That there are recognized effects in pul-
monary systems (Abraham et al. 2005) and
inhibitory effects on cathepsin catabolic
enzymes (Sudaranam et al. 1992) only serves
to illustrate the truly complex nature of the
toxicology arising from the family of polyether
natural products derived from K. brevis. Many
of these effects are only now becoming clear. A
nagging question is whether the pulmonary
receptor is associated with the epithelial
sodium channel (a ligand-gated ion channel)
or if it is a new orphan receptor. Further, the
inhibition of cathepsin within its active site by
brevetoxin points to another potential activity
for Florida red tide metabolites (Benson et al.
2005; Sudaranam et al. 1992).
We conclude that the toxicology surround-
ing exposure to Florida red tides involves mul-
tiple biotoxins and antagonists, and these
interact with at least three receptors located in
neuronal, pulmonary, and enzymatic regula-
tory systems of living organisms. The result is a
complex combination of acute and chronic
signs and symptoms in both animals and
humans exposed to aerosolized bioactive mate-
rials produced by K. brevis.
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